PAPER Bossa M, Zacur E, Olmos S,
SEARCH RESULTS
331254 RESULTS
PAPER Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, Yuan J, Xia K, Gronemeyer H, Flavell RA, Song W
Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.
J Biol Chem. 2011 Mar 18;286(11):9049-62. PubMed: 21216952PAPER Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR
Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation.
J Biol Chem. 2011 Mar 18;286(11):9646-56. PubMed: 21216965PAPER Wood WG, Igbavboa U, Müller WE, Eckert GP
Cholesterol asymmetry in synaptic plasma membranes.
J Neurochem. 2011 Mar;116(5):684-9. PubMed: 21214553PAPER Bai G, Chivatakarn O, Bonanomi D, Lettieri K, Franco L, Xia C, Stein E, Ma L, Lewcock JW, Pfaff SL
Presenilin-dependent receptor processing is required for axon guidance.
Cell. 2011 Jan 7;144(1):106-18. PubMed: 21215373PAPER Nicholson AM, Methner DN, Ferreira A
Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.
J Biol Chem. 2011 Jan 14;286(2):976-86. PubMed: 21047784PAPER Schneider LS
Fixing Alzheimer disease trials by improving process and methods.
Curr Alzheimer Res. 2010 Nov;7(7):564-5. PubMed: 21214512PAPER Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
Clin Nutr. 2011 Jun;30(3):297-302. PubMed: 21216507PAPER Roepke SK, Chattillion EA, von Känel R, Allison M, Ziegler MG, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Calleran S, Harmell AL, Grant I
Carotid plaque in Alzheimer caregivers and the role of sympathoadrenal arousal.
Psychosom Med. 2011 Feb-Mar;73(2):206-13. PubMed: 21217096Qiang Zhang
Buck InstituteUnited States
Aβ 1-16
ANTIBODY monoclonal laboratory IC16<br />(<a href="http://www.labome.org/expert/germany/university/pietrzik/claus-u-pietrzik-379816.html" target="_new">Claus U. Pietrzik</a>, Institute of Physiological Chemistry and Pathobioch
Mitchel Kling
Rowan-Virtua School of Osteopathic MedicineStratford, United States
PAPER MacDonald E, Van der Lee H, Pocock D, Cole C, Thomas N, VandenBerg PM, Bourtchouladze R, Kleim JA
A novel phosphodiesterase type 4 inhibitor, HT-0712, enhances rehabilitation-dependent motor recovery and cortical reorganization after focal cortical ischemia.
Neurorehabil Neural Repair. 2007 Nov-Dec;21(6):486-96. PubMed: 17823313PAPER Gallant M, Aspiotis R, Day S, Dias R, Dubé D, Dubé L, Friesen RW, Girard M, Guay D, Hamel P, Huang Z, Lacombe P, Laliberté S, Lévesque JF, Liu S, Macdonald D, Mancini J, Nicholson DW, Styhler A, Townson K, Waters K, Young RN, Girard Y
Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment.
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6387-93. PubMed: 20933411PAPER Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT
Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus.
Neuropsychopharmacology. 2009 Oct;34(11):2404-19. PubMed: 19516250Current Filters
No filters selected